CareDx, Inc. (CDNA) bonds
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3033% above fair value
$77.88−1.93 (-2.42%)
Close on Nov 13, 2026Market cap $4.09BP/E 32.6Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
CareDx reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in CareDx's 10-K for the period ended Apr 17, 2018
CareDx's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Perceptive Credit Agreement | $15.00M |
See a number that looks wrong?